We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Human-Centered AI Tool Predicts Patient’s Sepsis Risk Within Four Hours

By HospiMedica International staff writers
Posted on 28 Aug 2024
Print article
Image: The human-centered AI tool aims to improve sepsis management (Photo courtesy of 123RF)
Image: The human-centered AI tool aims to improve sepsis management (Photo courtesy of 123RF)

Sepsis, a critical and life-threatening response to infection, can quickly lead to organ failure and is highly difficult to diagnose due to its common symptoms such as fever, low blood pressure, and increased heart rate, which mimic many other conditions. Now, an innovative artificial intelligence (AI) tool designed to assist clinicians in making decisions about patients at risk of sepsis introduces a novel feature: it accounts for uncertainties in its predictions and suggests additional information, such as demographic data, vital signs, and lab test results, needed to enhance its accuracy.

The system, called SepsisLab, was developed by scientists at The Ohio State University (Columbus, OH, USA) based on feedback from doctors and nurses in emergency and intensive care settings, where sepsis frequently occurs. These healthcare professionals expressed concerns over existing AI tools that rely solely on electronic health records without incorporating clinical inputs. SepsisLab improves upon this by predicting sepsis risk within a four-hour window while actively identifying and quantifying the importance of missing patient data, visually informing clinicians how certain pieces of information can influence the risk assessment.

This AI system updates its predictions hourly as new patient data is incorporated, continuously refining its accuracy. It also provides clinicians with actionable insights, suggesting which laboratory tests might be most informative and estimating how different clinical interventions could alter the patient's risk of developing sepsis According to the research published Aug. 24 in KDD ’24: Proceedings of the 30th ACM SIGKDD Conference on Knowledge Discovery and Data Mining, incorporating just 8% additional data from lab results and other key variables can decrease uncertainty in the predictions by 70%, enhancing the tool’s accuracy in assessing sepsis risk by 11%.

“The existing model represents a more a traditional human-AI competition paradigm, generating numerous annoying false alarms in ICUs and emergency rooms without listening to clinicians,” said senior study author Ping Zhang, associate professor of computer science and engineering and biomedical informatics at Ohio State. “The idea is we need to involve AI in every intermediate step of decision-making by adopting the ‘AI-in-the-human-loop’ concept. We’re not just developing a tool – we also recruited physicians into the project. This is a real collaboration between computer scientists and clinicians to develop a human-centered system that puts the physician in the driver’s seat.”

Related Links:
The Ohio State University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Electric Drill
Orthodrive MBQ-701
New
Bone Marrow Biopsy Needle
BEST-LISAS

Print article

Channels

Surgical Techniques

view channel
Image: The magnetics microrobots removed blood clots from sheep iliac artery (Photo courtesy of University of Twente)

Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots

Cardiovascular conditions such as thrombosis pose a significant global health issue, with blood clots being responsible for one in four deaths worldwide each year. A blood clot can obstruct a blood vessel,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.